InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Explore the complete record of transactions filed by BOTHWELL IAN T, Chief Financial Officer. Officer active across 1 companies, notably Organicell Regenerative Medicine, Inc.. Cumulatively, 26 reports have been logged. Total volume traded: €188k. The latest transaction was disclosed on 17 June 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations26 total
15,000,000 shares
Common Stock
SEC:0001683168-21-005202·
15,000,000 shares
Common Stock
SEC:0001683168-21-005202:0·
€5,79250,000 shares@ €0.11586.5% of flow
Common Stock
SEC:0001683168-21-002663·
€5,79250,000 shares@ €0.11583.1% of flow
Common Stock
SEC:0001683168-21-002663:0·
€5,77550,000 shares@ €0.11556.5% of flow
Common Stock
SEC:0001683168-21-002587·
€5,77550,000 shares@ €0.11553.1% of flow
Common Stock
SEC:0001683168-21-002587:0·
€6,03350,000 shares@ €0.12073.2% of flow
Common Stock
SEC:0001683168-21-002506:0·
€6,03350,000 shares@ €0.12076.8% of flow
Common Stock
SEC:0001683168-21-002506·
€5,76950,000 shares@ €0.11546.5% of flow
Common Stock
SEC:0001683168-21-002428·
€5,76950,000 shares@ €0.11543.1% of flow
Common Stock
SEC:0001683168-21-002428:0·
€7,85750,000 shares@ €0.15718.8% of flow
Common Stock
SEC:0001683168-21-002362·
€7,85750,000 shares@ €0.15714.2% of flow
Common Stock
SEC:0001683168-21-002362:0·
€6,33240,000 shares@ €0.15837.1% of flow
Common Stock
SEC:0001683168-21-002284·
€6,33240,000 shares@ €0.15833.4% of flow
Common Stock
SEC:0001683168-21-002284:0·
€7,36250,000 shares@ €0.14728.3% of flow
Common Stock
SEC:0001683168-21-002229·
€7,36250,000 shares@ €0.14723.9% of flow
Common Stock
SEC:0001683168-21-002229:0·
€8,99950,000 shares@ €0.1810.1% of flow
Common Stock
SEC:0001683168-21-002143·
€8,99950,000 shares@ €0.184.8% of flow
Common Stock
SEC:0001683168-21-002143:0·
€11,17850,000 shares@ €0.223612.6% of flow
Common Stock
SEC:0001683168-21-002078·
€11,17850,000 shares@ €0.22365.9% of flow
Common Stock
SEC:0001683168-21-002078:0·
€11,28450,000 shares@ €0.225712.7% of flow
Common Stock
SEC:0001683168-21-001933·
€11,28450,000 shares@ €0.22576.0% of flow
Common Stock
SEC:0001683168-21-001933:0·
€12,53350,000 shares@ €0.250714.1% of flow
Common Stock
SEC:0001683168-21-001828·
€12,53350,000 shares@ €0.25076.7% of flow
Common Stock
SEC:0001683168-21-001828:0·
50,000 shares
Common Stock
SEC:0001683168-21-001788·
25 of 26 declarations
About BOTHWELL IAN T
Ian T. Bothwell is the Chief Financial Officer of Organicell Regenerative Medicine, Inc.
